Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-01-06

Cellular Senescence in The Cancer Microenvironment.

Satoru Meguro, Makoto Nakanishi

Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. · pubmed

Abstract

In this aging society, the number of patients suffering from age-related diseases, including cancer, is increasing. Cellular senescence is a cell fate that involves permanent cell cycle arrest. Accumulated senescent cells in tissues over time present senescence-associated secretory phenotype (SASP) and make the inflammatory context, disturbing the tumor microenvironment. In particular, the effect of senescent cancer-associated fibroblasts on cancer progression has recently come under the spotlight. Although scientific evidence on the impact of cellular senescence on cancer is emerging, the association between cellular senescence and cancer is heterogeneous and the comprehensive mechanism is still not revealed. Recently, a therapy targeting senescent cells, senotherapeutics, has been reported to be effective against cancer in preclinical research and even clinical trials. With further research, the development of senotherapeutics as a novel cancer therapy is expected.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper discusses cellular senescence and its role in the cancer microenvironment, which is relevant to aging research as it addresses a mechanism associated with age-related diseases. However, while it touches on senotherapeutics, the focus remains primarily on cancer treatment rather than directly addressing the root causes of aging or lifespan extension. Thus, it presents solid research but with limited impact on the broader field of longevity.

Author of this paper? Send a correction.